申请人:——
公开号:US20030119871A1
公开(公告)日:2003-06-26
A class of styryl amidine derivatives which are antagonists of the hum NMDA receptor, being selective for those containing the NR2B subunit, are active in the treatment and/or prevention of neurological and neurodegenerative disorders, in particular neuropathic pain and headache, specifically migraine, whils displaying fewer ataxic and related side-effects associated with other classes of NMDA receptor antagonists.
一类styryl amidine衍生物,它们是hum NMDA受体的拮抗剂,对含有NR2B亚基的受体具有选择性,在治疗和/或预防神经系统和神经退行性疾病方面具有活性,特别是神经病性疼痛和头痛,特别是偏头痛,同时显示出更少的共济失调和其他NMDA受体拮抗剂相关的副作用。